Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Journal of Visualized Experiments · 2023
DOI: 10.3791/64810 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2023. Written by Rakan El-Mayta and 4 co-authors. Institution: Department of Bioengineering, University of Pennsylvania. Major MEDLINE topics: COVID-19, Nanoparticles. Cited 17 times so far (Crossref); 40 references. Funded by: NCATS NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Abstract (original language)
Lipid nanoparticles (LNPs) have attracted widespread attention recently with the successful development of the COVID-19 mRNA vaccines by Moderna and Pfizer/BioNTech. These vaccines have demonstrated the efficacy of mRNA-LNP therapeutics and opened the door for future clinical applications. In mRNA-LNP systems, the LNPs serve as delivery platforms that protect the mRNA cargo from degradation by nucleases and mediate their intracellular delivery. The LNPs are typically composed of four components: an ionizable lipid, a phospholipid, cholesterol, and a lipid-anchored polyethylene glycol (PEG) conjugate (lipid-PEG). Here, LNPs encapsulating mRNA encoding firefly luciferase are formulated by microfluidic mixing of the organic phase containing LNP lipid components and the aqueous phase containing mRNA. These mRNA-LNPs are then tested in vitro to evaluate their transfection efficiency in HepG2 cells using a bioluminescent plate-based assay. Additionally, mRNA-LNPs are evaluated in vivo in C57BL/6 mice following an intravenous injection via the lateral tail vein. Whole-body bioluminescence imaging is performed by using an in vivo imaging system. Representative results are shown for the mRNA-LNP characteristics, their transfection efficiency in HepG2 cells, and the total luminescent flux in C57BL/6 mice.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Bioengineering, University of Pennsylvania.
- Department of Bioengineering, University of Pennsylvania; mjmitch@seas.upenn.edu.
Funding
- NCATS NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
Cite
APA
El-Mayta, R., Padilla, M. S., Billingsley, M. M., Han, X., & Mitchell, M. J. (2023). Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing. Journal of Visualized Experiments. https://doi.org/10.3791/64810
Vancouver
El-Mayta R, Padilla MS, Billingsley MM, Han X, Mitchell MJ. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing. Journal of Visualized Experiments. 2023. doi:10.3791/64810
BibTeX
@article{ElMayta2023,
author = {El-Mayta, Rakan and Padilla, Marshall S and Billingsley, Margaret M and Han, Xuexiang and Mitchell, Michael J},
title = {Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing},
journal = {Journal of Visualized Experiments},
year = {2023},
doi = {10.3791/64810}
}
EUVIMED